Literature DB >> 8331532

Kinetics of chloroquine uptake into isolated rat hepatocytes.

A C MacIntyre1, D J Cutler.   

Abstract

The kinetics of uptake of chloroquine into isolated rat hepatocytes were studied to further investigate whether they are consistent with accumulation of chloroquine at therapeutic concentrations that is predominantly due to lysosomal trapping. A mathematical model describing the disposition of weak bases in isolated hepatocytes was developed and fitted to the chloroquine uptake data, allowing estimation of permeability coefficients for un-ionized chloroquine transport across rate-limiting membranes (p0 = 5.9 +/- 0.5 cm. s-1). The results of these studies suggest that the lysosomal membrane is the rate-limiting membrane in uptake of chloroquine in isolated hepatocytes. The rate and extent of accumulation of chloroquine in isolated hepatocytes in the presence of 10 mM NH4Cl were decreased. These results are consistent with a reduction in lysosomal pH caused by NH4Cl. The kinetics of uptake of hydroxychloroquine, which is structurally similar to chloroquine, were also investigated. The results of these studies were also consistent with lysosomal trapping, although the p0 value for un-ionized hydroxychloroquine (p0 = 0.28 +/- 0.02 cm.s-1) was much lower than that for un-ionized chloroquine. The estimated p0 value for un-ionized chloroquine and hydroxychloroquine transport across the lysosomal membrane are of a similar magnitude to those reported for transport of these compounds across human erythrocyte membranes, suggesting a similar transport mechanism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8331532     DOI: 10.1002/jps.2600820610

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Identification and SAR Evaluation of Hemozoin-Inhibiting Benzamides Active against Plasmodium falciparum.

Authors:  Kathryn J Wicht; Jill M Combrinck; Peter J Smith; Roger Hunter; Timothy J Egan
Journal:  J Med Chem       Date:  2016-06-24       Impact factor: 7.446

2.  Physiologically Based Pharmacokinetics of Lysosomotropic Chloroquine in Rat and Human.

Authors:  Xin Liu; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2020-12-04       Impact factor: 4.030

3.  Differential stimulation of the Na+/H+ exchanger determines chloroquine uptake in Plasmodium falciparum.

Authors:  S Wünsch; C P Sanchez; M Gekle; L Grosse-Wortmann; J Wiesner; M Lanzer
Journal:  J Cell Biol       Date:  1998-01-26       Impact factor: 10.539

4.  Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum.

Authors:  P G Bray; O Janneh; K J Raynes; M Mungthin; H Ginsburg; S A Ward
Journal:  J Cell Biol       Date:  1999-04-19       Impact factor: 10.539

5.  The toxic effects of chloroquine and hydroxychloroquine on skeletal muscle: a systematic review and meta-analysis.

Authors:  Claudia Cristina Biguetti; Joel Ferreira Santiago Junior; Matthew William Fiedler; Mauro Toledo Marrelli; Marco Brotto
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

6.  Translational Modeling of Chloroquine and Hydroxychloroquine Dosimetry in Human Airways for Treating Viral Respiratory Infections.

Authors:  Aditya R Kolli; Florian Calvino-Martin; Julia Hoeng
Journal:  Pharm Res       Date:  2022-01-09       Impact factor: 4.200

7.  Pulmonary Delivery of Aerosolized Chloroquine and Hydroxychloroquine to Treat COVID-19: In Vitro Experimentation to Human Dosing Predictions.

Authors:  Aditya R Kolli; Tanja Zivkovic Semren; David Bovard; Shoaib Majeed; Marco van der Toorn; Sophie Scheuner; Philippe A Guy; Arkadiusz Kuczaj; Anatoly Mazurov; Stefan Frentzel; Florian Calvino-Martin; Nikolai V Ivanov; John O'Mullane; Manuel C Peitsch; Julia Hoeng
Journal:  AAPS J       Date:  2022-02-07       Impact factor: 4.009

8.  How Could In Vitro Antiviral Activity Be Applied to Optimize the Dosing Regimens of Candidates for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)?

Authors:  Ranran Jia; Hongyun Wang
Journal:  Clin Infect Dis       Date:  2021-07-15       Impact factor: 9.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.